PATENT CLAIM ANALYSIS

Application Number: 15920565
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to a vaccine for protecting a pig against diseases associated with porcine epidemic diarrhea virus. The vaccine commonly includes inactivated/killed PEDV (e.g., chemically inactivated PED virus), and/or recombinant PEDV antigen and an adjuvant. Methods for protecting pigs against diseases associated with PEDV and methods of producing the porcine epidemic diarrhea virus vaccine are also provided.

Claim (Index 12):
The method of  claim 11 , wherein the PEDV antigen comprises:\n a. an isolated nucleic acid encoding an antigen of porcine epidemic diarrhea virus (PEDV) spike protein, wherein the recombinant Spike polypeptide has at least 95% homology with SEQ ID NO:3, 7, 9 or 14, b. a recombinant vector comprising the isolated nucleic acid of a), c. the recombinant PEDV Spike protein encoded by the nucleic acid of a), and d. any combination thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.46667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14672631', '15324908', '14716481', '14917620', '15509999']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7120998888350941
- 35 USC 102 Novelty (BERT): 0.6051470746108837
- Combined Prediction Score: 0.7014046074126731
- Mean Citation Score: 442.19035
- Max Citation Score: 629.9135
- Similarity Product: 432.6653308832348

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test